Pretreatment with ibrutinib facilitates rapid drug desensitization in a difficult case of brentuximab vedotin-induced anaphylaxis

J Allergy Clin Immunol Pract. 2023 Feb;11(2):642-644.e1. doi: 10.1016/j.jaip.2022.10.017. Epub 2022 Oct 22.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anaphylaxis* / diagnosis
  • Anaphylaxis* / drug therapy
  • Brentuximab Vedotin / therapeutic use
  • Humans
  • Immunoconjugates*
  • Piperidines / therapeutic use

Substances

  • Brentuximab Vedotin
  • ibrutinib
  • Immunoconjugates
  • Piperidines